Skip to product information
1 of 8

Agri Shield USA

Posilac 500mg – Recombinant Bovine Somatotropin (rbST) for Dairy Production

Posilac 500mg – Recombinant Bovine Somatotropin (rbST) for Dairy Production

Regular price $850.00 USD
Regular price Sale price $850.00 USD
Sale Sold out
Shipping calculated at checkout.
Quantity
$850.00 USD
$833.00 USD

Auto-renews, skip or cancel anytime.

To add to cart, go to the product page and select a purchase option

Posilac is a recombinant bovine somatotropin (rbST) designed to support increased milk production in lactating dairy cows. When administered according to labeled directions, Posilac helps improve feed efficiency by directing more nutrients toward milk synthesis, enabling producers to optimize productivity within their existing herd. It is backed by extensive research and regulated for use in dairy operations to support consistent, reliable performance.

View full details

Processor-Facing FAQs

What role does Agrishield Animal Health play regarding Posilac®?

Agrishield Animal Health serves as a distributor of Posilac® for Union Agener. Our role is limited to product distribution and the provision of accurate, approved product information. Agrishield Animal Health does not promote use, make production claims, or provide veterinary or management recommendations.

Does distribution of Posilac® imply processor or market endorsement?

No. Distribution of Posilac® does not imply endorsement by dairy processors, cooperatives, retailers, or other market participants. Decisions regarding the use or acceptance of Posilac® are determined independently by producers and their downstream market partners.

How does Posilac® use relate to processor or cooperative policies?

Processor and cooperative policies may establish standards or requirements that affect whether Posilac® is used within a given supply chain. Producers are responsible for understanding and complying with all applicable processor, cooperative, and market-specific policies.

Is Posilac® use required or encouraged?

No. Use of Posilac® is optional and is a management decision made by individual producers in consultation with their licensed veterinarian and in consideration of regulatory requirements and market policies.

How is compliance with labeling and regulations addressed?

Posilac® is approved by the U.S. Food and Drug Administration (FDA) and must be used in accordance with approved labeling and applicable laws and regulations. Compliance with use requirements is the responsibility of the producer, with veterinary oversight as appropriate.

Does Posilac® affect milk safety or regulatory milk standards?

Milk sold in the United States is subject to federal and state safety standards regardless of farm management practices. Regulatory oversight of milk safety is administered through established food safety and quality assurance programs.

Where can processors obtain additional regulatory information?

Regulatory information regarding Posilac® is available through FDA-approved labeling and publicly available regulatory resources. Questions related to on-farm use should be directed to the producer and their licensed veterinarian.